ArticleJACC. Asia2022

Real-World Management of Pharmacological Thromboprophylactic Strategies for COVID-19 Patients in Japan: From the CLOT-COVID Study.

Hiroya Hayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.